Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1974 of 6351
-
Scientists map the Brain's 'Ad Hoc' programming ability
Knowledge-focused Recruiting nowHumans have a remarkable ability to flexibly interact with the environment. A compelling demonstration of this cognitive flexibility is human's ability to respond correctly to novel contextual situations on the first attempt, without prior rehearsal. The investigators refer to th…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Could a treadmill routine sharpen the diabetic brain?
Disease control Stopped earlyThis proposed study will advance science by providing evidence on the feasibility of a standardized, rigorously designed and delivered exercise program to improve cognition and plasma brain-derived neurotrophic factor (BDNF) levels for individuals with type 2 diabetes. We will al…
Sponsor: Florida State University • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can brain activity reveal why some people with depression lose motivation and pleasure?
Knowledge-focused CompletedDeficits in motivation and pleasure are common in depression, and thought to be caused by alterations in the ways in which the brain anticipates, evaluates, and adaptively uses reward-related information. However, reward processing is a complex, multi-circuit phenomenon, and the …
Sponsor: San Francisco Veterans Affairs Medical Center • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
New glucose monitor aims to prevent dangerous low blood sugar in kids
Disease control OngoingThis is a prospective, multi-center, non-randomized, single-arm study intended to characterize the safety of the FreeStyle Libre 2 Flash Glucose Monitoring System when used to manage diabetes in pediatric and young adult patient populations.
Sponsor: Abbott Diabetes Care • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Which ablation strategy works best for persistent AF? major study seeks answers.
Disease control OngoingThe objective of this study is to compare the efficacy of three different ablation strategies in patients with persistent AF: 1. PV antral isolation alone (PVAI) 2. PV antral isolation plus ablation of drivers (PVAI+drivers) 3. PV antral isolation plus isolation of posterior wal…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug combo aims to shrink Hard-to-Treat pancreatic and ovarian tumors
Disease control OngoingThis phase I trial identifies the best dose, possible benefits and/or side effects of gemcitabine in combination with elimusertib (BAY 1895344) in treating patients with pancreatic, ovarian, and other solid tumors that have spread to other places in the body (advanced). Gemcitabi…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New drug combo aims to keep bladder cancer at bay after chemo
Disease control Recruiting nowThe main objectif is to determine the efficacy of a maintenance treatment combining Talazoparib and Avelumab after platinum-based chemotherapy in patients with locally advanced/metastatic urothelial carcinoma.
Phase 2 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New IV drug aims to jolt atrial fibrillation back to normal rhythm in minutes
Disease control OngoingThis Phase 2 study is a two-stage, serial cohort dose escalation and expansion study of a single 30-minute (IV) infusion of HBI-3000 for the conversion of patients with recent-onset atrial fibrillation (AF). Stage A is open label and all patients will receive HBI-3000. In each o…
Phase 2 • Sponsor: HUYABIO International, LLC. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New CAR t cocktail aims to tackle Hard-to-Treat myeloma
Disease control Stopped earlyThis is a global, open-label, multi-arm, multi-cohort, multi-center, phase 1/2 study to determine the safety, tolerability, efficacy, PK of bb2121 in combination with other therapies in adult subjects with R/RMM. The following combinations will be * Arm A will test bb2121 in co…
Phase 1 • Sponsor: Celgene • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Can acupuncture and ice chips beat chemo nerve damage?
Symptom relief CompletedThis phase II trial investigates how well oral cryotherapy plus acupressure and acupuncture compared with oral cryotherapy alone work in decreasing chemotherapy-induced peripheral neuropathy in patients with gastrointestinal cancer who are receiving oxaliplatin-based chemotherapy…
Phase 2 • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Can CBD replace antipsychotics for cannabis users with psychosis?
Disease control OngoingThis trial examines the efficacy of cannabidiol (CBD) versus risperidone for treatment of psychosis in patients with non affective-psychosis and lifetime use of cannabis.
Phase 2 • Sponsor: Lone Baandrup • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Zapping away chemo brain: new hope for cancer survivors?
Symptom relief CompletedThis project is aimed at the discovery of neuro-modulation techniques that may alleviate chemotherapy induced cognitive deficits (CICD), especially in executive (higher-order) cognitive function (EF).
Sponsor: Sneha Phadke • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Could a better tDCS protocol lift depression?
Symptom relief CompletedIn this project, the efficacy of different tDCS protocols in major depression will be investigated. The tDCS protocols have already been investigated in humans, and results showed that stimulation intensity has a different effect on tDCS long-term aftereffects based on the human …
Sponsor: The National Brain Mapping Laboratory (NBML) • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
New immunotherapy combo shows promise for Tough-to-Treat MDS
Disease control Stopped earlyThe purpose of the study was to find out if the new drug sabatolimab when given in combination with azacitidine and venetoclax, was safe and had beneficial effects in participants with high or very high risk myelodysplastic syndrome (MDS) who were not suitable for treatment with …
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Smart bed could help Parkinson's patients regain balance
Symptom relief OngoingParkinson's disease is frequently associated with impaired postural control, balance deficits, trunk misalignment, altered proprioception, and an increased risk of falls. These impairments may contribute to reduced mobility, pain, loss of independence, and decreased quality of li…
Sponsor: I.R.C.C.S. Fondazione Santa Lucia • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Shock vs magnet: which therapy is safer for depression?
Symptom relief OngoingThis study aims to compare the efficacy and safety profile of Magnetic Seizure Therapy and Electroconvulsive therapy.
Phase 2/3 • Sponsor: University of Sao Paulo • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Antibiotic-Free future: study tests stopping trachoma treatment
Disease control CompletedThe investigators propose a randomized controlled trial of discontinuation versus continuation of annual mass azithromycin distribution in hypoendemic communities of Maradi, Niger. The investigators will randomize communities with up to 20% Trachomatous Inflammation - Follicular …
Phase 4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Pre-Treatment workouts may boost strength in head and neck cancer patients
Symptom relief CompletedThe main purpose of this randomized-controlled trial is to evaluate the effects of prehabilitation based on exercise training (ET) on functional capacity in HNC patients treated with chemoradiotherapy (CRT). Forty-six participants will be randomized (1:1 ratio) into prehabilitati…
Sponsor: Associacao de Investigacao de Cuidados de Suporte em Oncologia • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Immunotherapy combo shows promise in early liver cancer trial
Disease control OngoingThe purpose of this study is to determine the safety and tolerability of neoadjuvant/adjuvant Nivolumab or Nivolumab plus Relatlimab in patients with HCC.
Phase 1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug combo trial aims to fight advanced cancers
Disease control Recruiting nowThe purpose of this study is to assess the safety, tolerability, and recommended dose(s) of BMS-986340 as monotherapy and in combination with nivolumab, docetaxel, or Pumitamig in participants with advanced solid tumors. This study is a first-in-human (FIH) study of BMS-986340 in…
Phase 1/2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC